We observed decreased BRG1 levels corresponding to increased expression of HLF in the cancer lines, whereas a very minor effect was observed in normal cells (Fig. 6l–n), suggesting that BRG1-HLF regulation may be more specific to cancer cells. The gene discussed is SMARCA4; the disease is cancer.